|
Hypoproteinemia, Hypercatabolic
|
0.710 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
β2-Microglobulin deficiency causes a complex immunodeficiency of the innate and adaptive immune system.
|
25702838 |
2015 |
|
Hypoproteinemia, Hypercatabolic
|
0.710 |
GeneticVariation
|
disease |
BEFREE |
We concluded that a beta(2)m gene mutation underlies the hypercatabolism and reduced serum levels of albumin and IgG in the two siblings with familial hypercatabolic hypoproteinemia.
|
16549777 |
2006 |
|
Hypoproteinemia, Hypercatabolic
|
0.710 |
GeneticVariation
|
disease |
UNIPROT |
Familial hypercatabolic hypoproteinemia caused by deficiency of the neonatal Fc receptor, FcRn, due to a mutant beta2-microglobulin gene.
|
16549777 |
2006 |
|
Hypoproteinemia, Hypercatabolic
|
0.710 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
|
Hypoproteinemia, Hypercatabolic
|
0.710 |
Biomarker
|
disease |
CTD_human |
|
|
|
|
Amyloidosis, familial visceral
|
0.700 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Hereditary systemic amyloidosis due to Asp76Asn variant β2-microglobulin.
|
22693999 |
2012 |
|
Amyloidosis, familial visceral
|
0.700 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Hereditary systemic amyloidosis due to Asp76Asn variant β2-microglobulin.
|
22693999 |
2012 |
|
Amyloidosis, familial visceral
|
0.700 |
GeneticVariation
|
disease |
UNIPROT |
Hereditary systemic amyloidosis due to Asp76Asn variant β2-microglobulin.
|
22693999 |
2012 |
|
Amyloidosis, familial visceral
|
0.700 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
|
Amyloidosis, familial visceral
|
0.700 |
Biomarker
|
disease |
CTD_human |
|
|
|
|
Acute kidney injury
|
0.500 |
Biomarker
|
disease |
CTD_human |
A Multiplatform Approach for the Discovery of Novel Drug-Induced Kidney Injury Biomarkers.
|
28885000 |
2017 |
|
Acute kidney injury
|
0.500 |
Biomarker
|
disease |
CTD_human |
Decrease in urinary creatinine in acute kidney injury influences diagnostic value of urinary biomarker-to-creatinine ratio in rats.
|
22005293 |
2011 |
|
Acute kidney injury
|
0.500 |
Biomarker
|
disease |
RGD |
Discrepancy between serum levels of low molecular weight proteins in acute kidney injury model rats with bilateral ureteral obstruction and bilateral nephrectomy.
|
19536607 |
2009 |
|
Acute kidney injury
|
0.500 |
Biomarker
|
disease |
CTD_human |
The effects of diltiazem on methotrexate-induced nephrotoxicity.
|
2689182 |
1989 |
|
Kidney Diseases
|
0.480 |
AlteredExpression
|
group |
BEFREE |
Lower serum level of β2-microglobulin and lower level of free light chain at diagnosis, achieving at least VGPR, and shorter kidney disease history are related to a high probability of dialysis independence in NDMM patients with serious renal failure requiring dialysis.
|
31663630 |
2020 |
|
Kidney Diseases
|
0.480 |
Biomarker
|
group |
BEFREE |
Patients who had AIP with IgG4-RKD were more likely to have extrapancreatic lesions other than those in the kidney, and their serum creatinine and urinary β2-microglobulin concentrations were significantly higher than in those without IgG4-RKD.
|
30826634 |
2019 |
|
Kidney Diseases
|
0.480 |
Biomarker
|
group |
BEFREE |
The detection of B2M and CC16 with the C18 plate-MALDI-TOF MS approach could be an attractive and practical assay for rapid diagnosis of nephropathy in nondiabetic/diabetic patients and as a predictor of ERFD among T2D patients who had not manifested significant kidney disease at baseline.
|
30024955 |
2018 |
|
Kidney Diseases
|
0.480 |
Biomarker
|
group |
BEFREE |
This study will provide important data about the local epidemiology of kidney disease in a high-risk rural setting and the utility of emerging renal filtration markers (Beta 2 Microglobulin and Cystatin C), while generating data and methods for the analyses of microRNA biomarkers.
|
29486722 |
2018 |
|
Kidney Diseases
|
0.480 |
AlteredExpression
|
group |
BEFREE |
We assessed if elevated levels of B2M would associate with either the diagnosis of AKI [under current Kidney Disease: Improving Global Outcomes (KDIGO) criteria] or recovery from AKI.
|
30524714 |
2018 |
|
Kidney Diseases
|
0.480 |
Biomarker
|
group |
BEFREE |
Rediscovering Beta-2 Microglobulin As a Biomarker across the Spectrum of Kidney Diseases.
|
28664159 |
2017 |
|
Kidney Diseases
|
0.480 |
Biomarker
|
group |
BEFREE |
Beta-2-microglobulin (B2M) expression in the urinary sediment correlates with clinical markers of kidney disease in patients with type 1 diabetes.
|
27173460 |
2016 |
|
Kidney Diseases
|
0.480 |
Biomarker
|
group |
CTD_human |
Identification of urinary miRNA biomarkers for detecting cisplatin-induced proximal tubular injury in rats.
|
24863737 |
2014 |
|
Kidney Diseases
|
0.480 |
Biomarker
|
group |
CTD_human |
Estimation of benchmark dose for pancreatic damage in cadmium-exposed smelters.
|
17303580 |
2007 |
|
Kidney Diseases
|
0.480 |
Biomarker
|
group |
BEFREE |
In fact, in this review, the editors have chosen to review the beta 2-microglobulin amyloid of long-term hemodialysis in the section on renal disease.
|
1543671 |
1992 |
|
Kidney Diseases
|
0.480 |
Biomarker
|
group |
CTD_human |
Assessment of urinary rat beta 2-microglobulin by enzyme immunoassay.
|
2202081 |
1990 |